WallStSmart

ReWalk Robotics Ltd (LFWD)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 120676% more annual revenue ($25.27B vs $20.92M). SYK leads profitability with a 13.2% profit margin vs -123.7%. SYK earns a higher WallStSmart Score of 57/100 (C).

LFWD

Avoid

23

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -18.73

SYK

Buy

57

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LFWD.

SYKSignificantly Overvalued (-57.3%)

Margin of Safety

-57.3%

Fair Value

$224.01

Current Price

$352.25

$128.24 premium

UndervaluedFair: $224.01Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LFWD0 strengths · Avg: 0/10

No standout strengths identified

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$118.55B9/10

Large-cap with strong market position

Areas to Watch

LFWD4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$20.02M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.403/10

Elevated debt levels

Return on EquityProfitability
-209.1%2/10

ROE of -209.1% — below average capital efficiency

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
36.4x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : LFWD

LFWD has a balanced fundamental profile.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap.

Bear Case : LFWD

The primary concerns for LFWD are EPS Growth, Market Cap, Debt/Equity.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

LFWD profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.

SYK carries more volatility with a beta of 0.78 — expect wider price swings.

SYK is growing revenue faster at 2.6% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

SYK scores higher overall (57/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ReWalk Robotics Ltd

HEALTHCARE · MEDICAL DEVICES · USA

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?